| 书目名称 | Clinical and Biological Basis of Lung Cancer Prevention |
| 编辑 | Yves Martinet,Fred R. Hirsch,James L. Mulshine |
| 视频video | http://file.papertrans.cn/229/228292/228292.mp4 |
| 丛书名称 | Respiratory Pharmacology and Pharmacotherapy |
| 图书封面 |  |
| 描述 | Lung cancer is a disease with pandemic public health implications as it is now the leading cause of cancer mortality throughout the world. This book results from two recent International Association for the Study of Lung Cancer (IASLC) Workshops on lung cancer prevention. It strikes a balance between considering public health approaches to tobacco control and population-based screening, advances in clinical evaluation of chemoprevention approaches, and the biology of lung carcinogenesis. Indeed, while the science of smoking cessation is evolving as new pharmacological tools are moving into clinical evaluation, the current impact of molecular diagnostics is profound. The rapidly-evolving diagnostic technologies are revolutionizing basic scientific investigation of cancer, and this trend is expected to soon spill over into the clinical practice of medicine. The evolution of economical diagnostic platforms to allow for direct bronchial epithelial evaluation in high-risk populations promises to improve the diagnostic lead-time for this disease. The hope is that enough progress will occur to permit lung cancer detection in advance of clinical cancer so that the disease can be addressed |
| 出版日期 | Book 1998 |
| 关键词 | Public Health; Respiratory research; biology; cancer; cancer prevention; cancer research; carcinogenesis; d |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-3-0348-8924-7 |
| isbn_softcover | 978-3-0348-9829-4 |
| isbn_ebook | 978-3-0348-8924-7 |
| copyright | Springer Basel AG 1998 |
|Archiver|手机版|小黑屋|
派博传思国际
( 京公网安备110108008328)
GMT+8, 2025-8-29 21:46
发表于 2025-3-21 19:56:22
